The potential therapeutic value of targeting IL-6 existsfor oral oncology since anti-IL-6 agents are already being tested for cancer patients in other treatment settings [12].Researchers face limitations when they use IL-6 marker despite its potential value for diagnostics. This evidence concerns the gene IL6 and cancer.